Most leukemia treatments today
focus on chemotherapy, steroid drugs and stem - cell transplants.
But its results were unpredictable, and the concept of cancer immunotherapy fell out of favor as the field
focused on chemotherapy and radiation.
Not exact matches
«For years, researchers have
focused on delivering more
chemotherapy drugs into cancer cells using nanoparticles, without targeting the root of drug resistance,» He said.
Bogyo and his associates
focused on a compound called ebselen because, in addition to having a strong inhibitory effect, ebselen also has been tested in clinical trials for
chemotherapy - related hearing loss and for stroke.
In future, Bandyopadhyay says, better understanding how
chemotherapy agents impact specific biological pathways should allow drug trials to
focus on patients who are more likely to respond to the drugs being tested and enable clinicians to identify targeted or combination therapies for patients with a genetic predisposition to resistance.
«The
focus of
chemotherapy and existing standard - of - care is
on killing cancer cells but instead we took a completely different approach which changes the environment the cancer cells live in,» said Mick Bhatia, director and senior scientist with the McMaster Stem Cell and Cancer Research Institute, who led the group that performed the study.
But this study took a different approach — rather than just
focusing on antibiotic - resistant strains, the study tapped into an unbiased collection of 1509 E. coli, the majority of which were from the British Society of Antimicrobial
Chemotherapy Bacteraemia Surveillance programme collected over 11 years from across England.
«We only
focused on a class of
chemotherapy used to treat colon and breast cancer called topoisomerase I inhibitors.
The collection contains over 20,000 different samples of Salmonella, with half of the samples housed at the Cancer Research Center where researchers affiliated with MU
focus on three areas of cancer research: early detection, targeted treatment and new, effective
chemotherapy.
Dr. Innocentis NIH - funded research program is currently
focused on the discovery of genomic determinants of efficacy and toxicity of cancer
chemotherapy, integrating clinical genomic investigation with functional evaluation of gene variation.
Our current research
focuses on how these genetic and expression differences play a role in sensitivity to adverse effects associated with
chemotherapy.»
Focused on the treatment of cancers and blood disorders, as well as directing
chemotherapy care, the hematologists and oncologists at Wake Forest Baptist Health work as part of a team of specialists to provide the best possible care in North Carolina.
Cancer immunotherapy is
focused on the immune system and is often more targeted than conventional cancer treatments such as
chemotherapy or radiation
Working with a group of 16 cancer survivors, all but one of who recently finished
chemotherapy cancer treatment, the researchers
focused on T cells, a type of immune cell that attacks a variety of infectious agents as well as cancer cells.
Their research has
focused on multiple scenarios of drugs, including those targeted for gene therapy or
chemotherapy, but all rely
on the same nanoscale drug delivery mechanism or «nanodepot.»
CRI postdoctoral fellow Jeffrey Chou, M.D., Ph.D., of the Fred Hutchinson Cancer Research Center, with his sponsor Edus Warren, M.D., Ph.D., is
focusing on developing a new treatment approach that combines low - dose
chemotherapy with immunotherapy.
Recent clinical trials have
focused on endobronchial intratumoral
chemotherapy, which is the direct injection of the drug into the tumor.
Conventional treatments such as surgery and
chemotherapy only
focus on the tumor but fail to address the underlying problems.
Her research
focuses on local
chemotherapy treatment for brain tumors, including a potentially ground - breaking drug that has led to a clinical trial.
The research
focuses on how radiation and
chemotherapy might be used to ease pain in dogs suffering from this debilitating disease.
One plan
focuses on palliative care while the other includes
chemotherapy.
Afternoons we
focus on treatments like
chemotherapy or doing things like biopsies.
We decided against
chemotherapy post-surgery; instead, we
focused on maintaining Sampson's quality of life in as pain - free a manner as possible.
Our approach to
chemotherapy in veterinary medicine is
focused on limiting severe side effects.
Her research has
focused on dermatologic side - effects of
chemotherapy in dogs and
on the common auto - immune diseases, pemphigus foliaceus and perianal fistulas.